These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6444813)

  • 21. The action of antithrombin III on plasmin and activators of plasminogen.
    Crawford GP; Ogston D
    Biochim Biophys Acta; 1975 May; 391(1):189-92. PubMed ID: 124592
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical characterization including amino acid and carbohydrate compositions of canine and human brain Thy-1 antigen.
    McKenzie JL; Allen AK; Fabre JW
    Biochem J; 1981 Sep; 197(3):629-36. PubMed ID: 6119980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubilization of the plasmin receptor from human carcinoma cells.
    Burtin P; Fondaneche MC
    Biochem Biophys Res Commun; 1990 Jul; 170(2):748-54. PubMed ID: 2166506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
    Komorowicz E; Kolev K; Machovich R
    Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental animal research on the thrombolytic effect of acyl-plasmin].
    Nowak G; Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):144-50. PubMed ID: 2427395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of structural features of macroglobulins complexed with plasmin].
    Zhabin SG; Zorin NA; Gorin VS; Lykova OF
    Vopr Med Khim; 1993; 39(4):53-6. PubMed ID: 8379118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ; Minkema J; Bouma BN; Jansen JW
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fate of the factor-13-mediated fibrin crosslinks during clot lysis.
    Gaffney PJ
    Br J Haematol; 1973 Aug; 25(2):277. PubMed ID: 4269482
    [No Abstract]   [Full Text] [Related]  

  • 31. Haptoglobin typing in canine bloods.
    Harrington J; Heaney H; McSweeney C; Quarino L; Schwartz T; Versoza J
    J Forensic Sci; 1991 Sep; 36(5):1561-4. PubMed ID: 1955840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some consequences of the covalent and non-covalent binding modes of plasmin with alpha 2-macroglobulin.
    Pochon F
    Biochim Biophys Acta; 1987 Sep; 915(1):37-45. PubMed ID: 2441753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NH2-terminal amino acids of the fibrinogen degradation products. Implications for fibrinogen structure.
    Marder VJ; Budzynski AZ
    Thromb Diath Haemorrh Suppl; 1973; 56():127-35. PubMed ID: 4281939
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N; Davies A; Fletcher A
    Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specific proteolysis by fibrinolysin-coagulase from Yersinia pestis of Yersinia pseudotuberculosis outer membrane proteins coded by the Ca(2+)-dependence plasmid].
    Shmelev VA; Cherepanov PA; Nosova LIu; Karimova GA; Popov SG; Noskov AN
    Mol Gen Mikrobiol Virusol; 1991 Jan; (1):21-4. PubMed ID: 1827173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective neutralization of the serpin protease nexin-1 by a specific monoclonal antibody.
    François D; Venisse L; Brouwers E; Arocas V; Declerck P; Bouton MC
    Br J Haematol; 2016 Feb; 172(4):631-3. PubMed ID: 26010932
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
    Regañon E; Aznar J; Vila V
    Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of endogenous plasmin to convert human growth hormone to its "activated" isohormones.
    Baumann G
    J Clin Endocrinol Metab; 1976 Jul; 43(1):222-5. PubMed ID: 133116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.